Trials / Unknown
UnknownNCT04958174
A Smartphone Application for Screening of Developmental Disorders in Children
A Smartphone Application for Screening of Developmental Disorders in Children: a Prospective Feasibility Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (estimated)
- Sponsor
- Weprom · Academic / Other
- Sex
- All
- Age
- 1 Month – 3 Years
- Healthy volunteers
- —
Summary
The detection of developmental disorders in the child is often late because the parents do not have the information necessary to consult at the first clinical signs. For example, the diagnosis of autism spectrum disorders is made at the age of 5, so earlier diagnoses are possible earlier or even in the 1st year with appropriate questionnaires. An application (Malo) has been developed to allow through regular questionnaires from 1 month to 3 years old to assess the child's development by his parents in the form of a digital health record assessing several areas at regular intervals (monthly the 1st year then every 3 to 12 months): sensory, psychomotor development, sleep, height and weight, cognitive and addictions (especially to screens). The questions will be adapted to the age of the child. An alert suggesting to consult the general practitioner or the pediatrician will be generated according to an algorithm validated by a committee of experts. Based on a study model on health data already carried out as part of the triage application for patients suspected of COVID 19 coronavirus disease.fr with 14 million users in 6 months having improved the relevance of calls to the 15 (8 times fewer unnecessary calls) and general practitioners. This study will assess parental interest in this application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | web-application | web application for monitoring children's development |
Timeline
- Start date
- 2021-08-15
- Primary completion
- 2023-02-15
- Completion
- 2023-02-15
- First posted
- 2021-07-12
- Last updated
- 2021-12-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04958174. Inclusion in this directory is not an endorsement.